AU2003221173A1 - Placenta-origin mesenchymal cells and medicinal use thereof - Google Patents

Placenta-origin mesenchymal cells and medicinal use thereof

Info

Publication number
AU2003221173A1
AU2003221173A1 AU2003221173A AU2003221173A AU2003221173A1 AU 2003221173 A1 AU2003221173 A1 AU 2003221173A1 AU 2003221173 A AU2003221173 A AU 2003221173A AU 2003221173 A AU2003221173 A AU 2003221173A AU 2003221173 A1 AU2003221173 A1 AU 2003221173A1
Authority
AU
Australia
Prior art keywords
placenta
mesenchymal cells
medicinal use
origin mesenchymal
origin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003221173A
Inventor
Koichi Igura
Tsuneo Takahashi
Nobukazu Watanabe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Kasei Corp
Nipro Corp
Asahi Kasei Medical Co Ltd
Original Assignee
Asahi Medical Co Ltd
Asahi Kasei Corp
Nipro Corp
Asahi Chemical Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Medical Co Ltd, Asahi Kasei Corp, Nipro Corp, Asahi Chemical Industry Co Ltd filed Critical Asahi Medical Co Ltd
Publication of AU2003221173A1 publication Critical patent/AU2003221173A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0668—Mesenchymal stem cells from other natural sources
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
AU2003221173A 2002-03-27 2003-03-26 Placenta-origin mesenchymal cells and medicinal use thereof Abandoned AU2003221173A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
JP2002089996 2002-03-27
JP2002-89996 2002-03-27
JP2002-295721 2002-10-09
JP2002295721 2002-10-09
JP2003-64112 2003-03-10
JP2003064112 2003-03-10
PCT/JP2003/003760 WO2003080822A1 (en) 2002-03-27 2003-03-26 Placenta-origin mesenchymal cells and medicinal use thereof

Publications (1)

Publication Number Publication Date
AU2003221173A1 true AU2003221173A1 (en) 2003-10-08

Family

ID=28457596

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003221173A Abandoned AU2003221173A1 (en) 2002-03-27 2003-03-26 Placenta-origin mesenchymal cells and medicinal use thereof

Country Status (3)

Country Link
JP (1) JPWO2003080822A1 (en)
AU (1) AU2003221173A1 (en)
WO (1) WO2003080822A1 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1641914B1 (en) 2003-06-27 2016-07-20 DePuy Synthes Products, Inc. Postpartum cells derived from placental tissue, and methods of making and using the same
US9592258B2 (en) 2003-06-27 2017-03-14 DePuy Synthes Products, Inc. Treatment of neurological injury by administration of human umbilical cord tissue-derived cells
US7875272B2 (en) 2003-06-27 2011-01-25 Ethicon, Incorporated Treatment of stroke and other acute neuraldegenerative disorders using postpartum derived cells
US8790637B2 (en) 2003-06-27 2014-07-29 DePuy Synthes Products, LLC Repair and regeneration of ocular tissue using postpartum-derived cells
US9572840B2 (en) 2003-06-27 2017-02-21 DePuy Synthes Products, Inc. Regeneration and repair of neural tissue using postpartum-derived cells
GB0329449D0 (en) * 2003-12-19 2004-01-28 Omnicyte Ltd Stem cells
JP4838981B2 (en) * 2004-01-26 2011-12-14 直秀 山下 A topical skin preparation containing mesenchymal cells derived from human placenta
US20060069008A1 (en) 2004-09-28 2006-03-30 Sanjay Mistry Treatment of neurological deficits in the striatum or substanta nigra pars compacta
WO2006071802A2 (en) 2004-12-23 2006-07-06 Ethicon Incorporated Treatment of stroke and other acute neural degenerative disorders using postpartum derived cells
PL1971681T3 (en) 2005-12-16 2018-01-31 Depuy Synthes Products Inc Compositions and methods for inhibiting adverse immune response in histocompatibility-mismatched transplantation
US9125906B2 (en) 2005-12-28 2015-09-08 DePuy Synthes Products, Inc. Treatment of peripheral vascular disease using umbilical cord tissue-derived cells
ES2711278T3 (en) 2005-12-29 2019-04-30 Celularity Inc Populations of placental stem cells
EP2420567A3 (en) * 2006-10-23 2015-09-30 Anthrogenesis Corporation Methods and compositions for treatment of bone defects with placental cell populations
PT103843B (en) * 2007-10-04 2008-08-12 Medinfar Produtos Farmaceutico PRECURSOR CELL ISOLATION METHOD FROM THE HUMAN UMBILICAL CORD
GB0818725D0 (en) 2008-10-13 2008-11-19 Habib Nagy A Pharmaceutical composition
US10179900B2 (en) 2008-12-19 2019-01-15 DePuy Synthes Products, Inc. Conditioned media and methods of making a conditioned media
AU2009327384B2 (en) 2008-12-19 2014-07-10 DePuy Synthes Products, LLC Treatment of lung and pulmonary diseases and disorders
CN102498204B (en) 2009-03-26 2015-02-04 德普伊新特斯产品有限责任公司 Human umbilical cord tissue cells as therapy for Alzheimer's disease
AU2011352036A1 (en) 2010-12-31 2013-07-18 Anthrogenesis Corporation Enhancement of placental stem cell potency using modulatory RNA molecules
CN113559126A (en) 2011-06-01 2021-10-29 人类起源公司 Treatment of pain using placental stem cells
AU2012358810B2 (en) 2011-12-23 2018-03-15 DePuy Synthes Products, Inc. Detection of human umbilical cord tissue-derived cells
CA3093069A1 (en) * 2018-03-06 2019-09-12 Epibone, Inc. Injectable off-the-shelf cartilage, tendon, and ligament repair compositions and methods of use
CN108324927B (en) * 2018-05-04 2021-08-03 上海市内分泌代谢病研究所 Application of osteocalcin in preparing medicine for treating Parkinson's disease

Also Published As

Publication number Publication date
WO2003080822A1 (en) 2003-10-02
JPWO2003080822A1 (en) 2005-07-28

Similar Documents

Publication Publication Date Title
AU2003221173A1 (en) Placenta-origin mesenchymal cells and medicinal use thereof
AU2003217350A1 (en) Proliferated cell lines and uses thereof
AU2003259055A1 (en) Cell and tissue culture device
AU2003281736A1 (en) Electrodes and related devices
AU2003214945A1 (en) Multi-function catheter and use thereof
AU2003272187A1 (en) Novel nanoparticles and use thereof
AU2002225681A1 (en) Yeast-dentritic cell vaccines and uses thereof
AU2003256641A1 (en) High capacity and high rate batteries
EP1519431A4 (en) Electrode and cell comprising the same
AU2002364051A1 (en) Anti-cancer combination and use thereof
AU2001264763A1 (en) Human mesenchymal progenitor cell
AU2003296369A1 (en) Imminoamines and preparation thereof
AU2003281691A1 (en) Furoisoquinoline derivative and use thereof
AU2003218261A1 (en) Improvements in pharmaceutical discovery and development
AU2003207628A1 (en) Structural and cytoskeleton-associated proteins
AU2003231827A1 (en) Pseudo-tissues and uses thereof
AU2003284460A1 (en) Medicinal composition
AU2003220966A1 (en) Drug containing human placenta-origin mesenchymal cells and process for producing vegf using the cells
AU2003280799A1 (en) Medicinal composition
AU2003215767A1 (en) Devices for use in medicine
AU2003302173A1 (en) Spirotetrathiocarbamates and spirooxothiocarbamates
AU2003264474A1 (en) Novel uracil derivatives and medicinal use thereof
AU2003240446A1 (en) Use of mob-5 in pain
AU2003220265A1 (en) Tamperproof and counterfeit-resistant structure
AU2002214307A1 (en) T cell line and use thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase